The use of remdesivir outside of clinical trials during the COVID-19 pandemic

The use of remdesivir outside of clinical trials during the COVID-19 pandemic

Abstract With a scientific background from filoviruses, paramyxoviruses, SARS-CoV, and MERS-CoV, remdesivir entered into the COVID-19 battle to become one of the favorable therapeutic candidates with potential antiviral activity in the treatment of this disease. Globally, remdesivir was accessed and...

Full description

Bibliographic Details
Main Authors: Vesa Halimi, Armond Daci, Nevenka Ridova, Irina Panovska-Stavridis, Milena Stevanovic, Venko Filipce, Aleksandar Dimovski, Aleksandra Grozdanova
Format: Article
Language:English
Published: BMC 2020-09-01
Series:Journal of Pharmaceutical Policy and Practice
Subjects:
COVID-19
Remdesivir
Clinical practice
Clinical trials
Expanded access
Compassionate use
Online Access:http://link.springer.com/article/10.1186/s40545-020-00258-8

Internet

http://link.springer.com/article/10.1186/s40545-020-00258-8

Similar Items